Enroll until October 31st
Elite 3D ex vivo screen featuring scientist-curated biologically relevant organoids with key G12D, G12V, G12R KRAS mutants and wild type models for evaluation of pancreatic cancer therapeutics
TumorGraft3D models are advanced preclinical tools engineered to replicate human cancer within a three-dimensional (3D) environment. These models emulate the cellular heterogeneity and microenvironment of tumors, offering a more precise representation of tumor biology. Evaluating your pancreatic cancer therapeutics using 3D organoids, which include models with critical mutations such as KRAS G12D, G12V, and G12R, is essential for mirroring patient responses in the clinic.
14 Clinically Relevant Models
Diverse bank of 3D tumor models mirroring the clinical and molecular heterogeneity of the patients
Fast, Scalable, & Versatile
Rapid generation of insights through high-throughput endpoints
Proprietary Matrix-Free 3D Assay
A matrix-free assay with indication-specific media retaining key molecular characteristics
Exemplary TumorGraft3D results from two models CTG3D-0282 and CTG3D-0851